Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

Share Price is delayed by 15 minutes
Get Live Data
29.50    -0.90 (-2.96%)
Bid:
30.00
Ask:
30.50
Spread: 0.50 (1.667%)
Market Cap: £80.45m
GMR Live PriceLast checked at - London Stock Exchange

Intraday Gaming Realms Share Chart

Biofuels Update

9 Feb 2011 07:00

RNS Number : 9083A
Pursuit Dynamics PLC
09 February 2011
 



9 February 2011

Pursuit Dynamics PLC (AIM: PDX)

("PDX" or the "Company')

Biofuels update

PDX is pleased to announce today that its Ethanol Reactor System ("ERS") installation at Pacific Ethanol Inc.'s Columbia Plant near Boardman Oregon USA is now moving into commercial production. PDX and Pacific Ethanol are in the process of agreeing formal terms for the full commercial use of the ERS, which will start operating in the Optimization mode, and PDX expects that revenues will be generated during this calendar quarter.

The installation of the ERS at Boardman has confirmed its stability, quality and viability for the corn ethanol market. The installation at Boardman will also begin validating the Cycle Time mode, which will enable more cycles to be run, thereby enhancing the total volume of ethanol produced and the return to PDX.

 

Commenting on the announcement, Roel Pieper, CEO of PDX, said:

 

"Today's announcement is a significant milestone in the commercial development of our biofuels business and I am looking forward to announcing further commercial developments as the remainder of our bioethanol plants enter commercial production."

 

- Ends -

For Further Information, please contact:

 

PDX

Roel Pieper, CEO

Tel: +44 (0)1480 422050

Richard Webster, CFO

Financial Dynamics

Ben Foster

Marc Cohen

Tel: +44 (0) 20 7831 3113

Tel: +44 (0) 7802 877 241

 

 

Cenkos Securities

Ian Soanes

Max Hartley

Tel: +44 (0)20 7397 8924

Mirabaud Securities

Rory Scott

Tel: +44 (0) 20 7878 3360

 

 

 

 

 

Notes to Editors

 

About PDX

 

- PDX (AIM: PDX) owns and commercialises the PDX Atomiser and Reactor technologies that enable significant reductions in energy usage, process acceleration and result enhancement for a wide range of industrial processes and applications.

 

- The PDX business model is currently organised into six Lines of Business - Biofuels; Brewing, Food and Beverages; Public Health and Decontamination; Industrial Licensing; Water and New Ventures.

 

- PDX is headquartered in Huntingdon (UK) with an office in London (UK), Schaffhausen (Switzerland) and Connecticut (USA).

 

- Further information is available at the Company's website: www.pdx.biz 

 

- Publication quality photographs are available from FD.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXVLLBFLFZBBB
Date   Source Headline
1st May 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:02 amRNSShare Buyback Programme
31st Mar 20257:00 amRNSAnnual Results 2024
28th Feb 202512:05 pmRNSTotal Voting Rights and Share Capital
4th Feb 20257:00 amRNSFY24 Pre-Close Trading Update
29th Jan 20253:45 pmRNSBlock Listing Six Monthly Return
22nd Jan 20253:20 pmRNSHolding(s) in Company
11th Sep 20247:00 amRNSInterim Results
7th Aug 20243:00 pmRNSAdoption and grant of options
2nd Aug 20245:00 pmRNSShare Capital Reduction
30th Jul 20247:00 amRNSPre-Close Trading Update
29th Jul 20248:00 amRNSBlock Listing Six Monthly Return
27th Jun 20242:20 pmRNSTotal Voting Rights and Share Capital
14th Jun 20249:57 amRNSResult of AGM
2nd Apr 20247:01 amRNSInvestor Presentation
2nd Apr 20247:00 amRNSAnnual Results 2023
27th Mar 20244:05 pmRNSTotal Voting Rights and Share Capital
5th Feb 20247:00 amRNSPre-Close Trading Update
30th Jan 20244:00 pmRNSTotal Voting Rights and Share Capital
30th Jan 20244:00 pmRNSBlock Listing Six Monthly Return
30th Nov 20237:00 amRNSTotal Voting Rights and Share Capital
28th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSInterim Results
14th Aug 20237:00 amRNSDirector/PDMR Shareholding
7th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20234:59 pmRNSDirector/PDMR Shareholding
28th Jul 20232:00 pmRNSTotal Voting Rights and Share Capital
28th Jul 20232:00 pmRNSBlock Listing Six Monthly Return
27th Jul 20237:00 amRNSPre-Close Trading Update
30th Jun 20233:02 pmRNSTotal Voting Rights and Share Capital
31st May 202312:35 pmRNSResult of AGM
3rd Apr 20237:00 amRNSAnnual Results 2022
1st Feb 20237:00 amRNSPre-Close Trading Update and Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.